Literature DB >> 7452872

Cranial irradiation in cancer of the lung of all cell types.

J D Cox, K Stanley, Z Petrovich, C Paig, R Yesner.   

Abstract

The Veterans Administration Lung Group conducted a prospective study of irradiation for subclinical brain metastases in patients with inoperable carcinoma of the lung between 1975 and 1978. Patients were randomized to receive whole-brain irradiation (2,000 rads in two weeks) or no brain treatment, and to receive one of two regimens of thoracic irradiation. Three hundred twenty-three patients with normal radionuclide brain scans were able to be evaluated. The rate of clinical brain metastasis was 26% for patients with small cell carcinoma vs 10% for the "non-small-cell" group. A statistically insignificant decrease in the rate of brain metastasis was found among irradiated patients with small cell carcinoma. The frequency of brain metastasis in the non-small-cell patients was reduced from 13% to 6% by irradiation. Prophylactic cranial irradiation can decrease morbidity from non-small-cell carcinoma of the lung.

Entities:  

Mesh:

Year:  1981        PMID: 7452872

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Case closed: another prophylactic cranial irradiation trial for stage 3 non-small cell lung cancer fails to improve overall survival.

Authors:  Nuriel Moghavem; Heather A Wakelee; Seema Nagpal
Journal:  Ann Transl Med       Date:  2018-12

2.  The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.

Authors:  Qian-Xia Li; Xiao Zhou; Ting-Ting Huang; Yang Tang; Bo Liu; Ping Peng; Li Sun; Yi-Hua Wang; Xiang-Lin Yuan
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 3.  Radiation therapy in the prevention of brain metastases.

Authors:  Joseph A Bovi; Julia White
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

4.  Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer - Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes).

Authors:  Marzena Gawkowska-Suwińska; Sławomir Blamek; Alicja Heyda; Lukasz Boguszewicz; Anna Cichoń; Lukasz Zarudzki; Elżbieta Nowicka; Katarzyna Behrendt; Beata Smolska-Ciszewska; Grzegorz Plewicki; Aleksander Zajusz; Rafał Tarnawski
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17

5.  Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer.

Authors:  T Umsawasdi; M Valdivieso; T T Chen; H T Barkley; D J Booser; D F Chiuten; H M Dhingra; W K Murphy; C L Dixon; P Farha
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 6.  Radiotherapy in the management of non-small-cell lung cancer.

Authors:  A Bezjak; D Payne
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 7.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

Review 8.  Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.

Authors:  Rimas V Lukas; Maciej S Lesniak; Ravi Salgia
Journal:  CNS Oncol       Date:  2014-01

Review 9.  Prophylactic cranial irradiation: recent outcomes and innovations.

Authors:  James W Snider; Vinai Gondi; Paul D Brown; Wolfgang Tome; Minesh P Mehta
Journal:  CNS Oncol       Date:  2014-05

10.  Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.

Authors:  Ali Aydin Yavuz; Erkan Topkan; Cem Onal; Melek Nur Yavuz
Journal:  J Exp Clin Cancer Res       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.